Share this article
Share this article
WATERFALL, Pa., Dec. 21, 2020 /PRNewswire/ CapStone Holdings, a business incubator and investment group, today announced a $25 million investment in TerrAscend s Ilera Healthcare Division, a vertically-integrated medical marijuana cultivator, processor, and dispensary operator in Pennsylvania.
CapStone is one of a group of investors in a $120 million loan facility to enable Ilera s parent company – TerrAscend Corp. (CSE: TER;OTCQX: TRSSF) – to satisfy the final Ilera Healthcare earn-out payments, in connection with TerrAscend s acquisition of Ilera Healthcare, without the need for additional external funding.
Ilera and TerrAscend.is comprised of business leaders with decades of global management and finance experience.
Canopy Growth and TerrAscend s Arise Bioscience Enter Debt Financing Agreement
News provided by
Share this article
Canopy Growth completes US$20 million loan to Arise Bioscience Inc.
SMITHS FALLS and TORONTO, ON, Dec. 10, 2020 /PRNewswire/ - Canopy Growth Corporation ( Canopy Growth or the Company ) (TSX: WEED) (NASDAQ: CGC) and Arise Bioscience Inc. ( Arise ), a wholly owned subsidiary of TerrAscend Corp. ( TerrAscend ) (CSE: TER) (OTCQX: TRSSF) engaged only in the legal sale of CBD products, today announced they have entered into a loan financing arrangement in the amount of US$20 million (the Loan ) pursuant to a secured debenture (the Debenture ). In connection with the Loan, TerrAscend has issued 2,105,718 common share purchase warrants to the Company (the Warrants ).